<b>Study of drugs susceptibility and molecular samples evaluation of <em>Enterococcus</em> spp isolated in hospitalized patients</b> - DOI: 10.4025/actascihealthsci.v25i1.2249
Abstract
The aim of this study was to investigate the prevalency of Enterococcus spp, isolated from different clinical materials. The strains were evaluated for drugs susceptibility, typing by JB1-PCR and screened to the presence of Van A and Van B gene. From the 58 strains, 98.3% were classified as Enterococcus faecalis. All strains were sensible to nitrofurantoin and vancomycin, 96.6% were sensible to ampicilin, 32.8% were resistant to streptomycin, 10.3% were resistant to gentamicin and ciprofloxacin and 6.9% were resistant to norfloxacin. Using CIM test to check vancomycin susceptibility was observed bacterial growth until 4μg/ml. The presence of Van A e Van B gene was not detected. The amplification by JB1-PCR provided band patterns with up to 7 fragments and the samples were classified into 6 distint groups. The band patterns did not point out prevalence of any clone disseminated among strains. It was not possible to correlate genotype with antimicrobial resistance.Downloads
Download data is not yet available.
Published
2008-04-17
How to Cite
Bedendo, J., Siqueira, V. L. D., Cardoso, C. L., & Borelli, S. D. (2008). <b>Study of drugs susceptibility and molecular samples evaluation of <em>Enterococcus</em> spp isolated in hospitalized patients</b> - DOI: 10.4025/actascihealthsci.v25i1.2249. Acta Scientiarum. Health Sciences, 25(1), 35-40. https://doi.org/10.4025/actascihealthsci.v25i1.2249
Issue
Section
Health Sciences
DECLARATION OF ORIGINALITY AND COPYRIGHTS
I Declare that current article is original and has not been submitted for publication, in part or in whole, to any other national or international journal.
The copyrights belong exclusively to the authors. Published content is licensed under Creative Commons Attribution 4.0 (CC BY 4.0) guidelines, which allows sharing (copy and distribution of the material in any medium or format) and adaptation (remix, transform, and build upon the material) for any purpose, even commercially, under the terms of attribution.
Read this link for further information on how to use CC BY 4.0 properly.













5.png)





